Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Quality Index
Shanghai Rendu Biotechnology Co. Ltd. A cash flow quality index. Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow Quality Index of 2.22x as of December 2025. Operating cash flow of CN¥22.41 Million exceeds net income of CN¥10.09 Million, indicating high earnings quality where cash backs reported profits. See how financially flexible is Shanghai Rendu Biotechnology Co. Ltd. A to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Cash flow quality index of Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025. Historical Cash Flow Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Shanghai Rendu Biotechnology Co. Ltd. A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Quality Index by Year (2019–2025)
Shanghai Rendu Biotechnology Co. Ltd. A cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Shanghai Rendu Biotechnology Co. Ltd. A. For the full cash flow conversion analysis, see Shanghai Rendu Biotechnology Co. Ltd. A (688193) cash conversion ratio.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.22x | CN¥22.41 Million | CN¥10.09 Million | ▲ +6.7% |
| 2023 | 2.08x | CN¥17.19 Million | CN¥8.26 Million | ▲ +1287.0% |
| 2022 | -0.18x | CN¥-4.09 Million | CN¥23.33 Million | ▼ -120.8% |
| 2021 | 0.84x | CN¥54.44 Million | CN¥64.62 Million | ▼ -44.2% |
| 2020 | 1.51x | CN¥92.61 Million | CN¥61.38 Million | ▼ -58.7% |
| 2019 | 3.65x | CN¥13.67 Million | CN¥3.74 Million | — |